Skip to Content

M L23 (Lisinopril 5 mg)

Pill with imprint M L23 is Orange, Round and has been identified as Lisinopril 5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M L23

Lisinopril 5 mg M L23
Lisinopril 5 mg M L23
Lisinopril 5 mg M L23  Front
Lisinopril 5 mg M L23  Back
Lisinopril 5 mg M L23
Lisinopril 5 mg M L23


M L23
5 mg
8.00 mm
Prescription only
Drug Class:
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00378-2073 Mylan Pharmaceuticals Inc.
51079-0981 UDL Laboratories Inc.
63874-0558 Altura Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.